Gideon Shapiro

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 333 citations · Full text

Cancer Research, Mtap Loss, Medicine +10

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

Jos Prickaerts, Nick P. van Goethem, Richard Chesworth et al. · Neuropharmacology · 2011 · 202 citations

Acetylcholine Response, Cellular Neuroscience, Synaptic Transmission +9

Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro

Kazuhiro Gomi, B. Löwenberg, Gideon Shapiro et al. · Biomaterials · 1993 · 142 citations

Tissue Engineering, Engineering, Hydroxyapatite +7

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment

Jun Wu, Hsin-Pei Shih, V. A. Vigont et al. · Chemistry & Biology · 2011 · 141 citations

Disease Treatment, Medicine, Neurotransmitter +10

Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension

Batya Kristal, Judith Chezar, J. Manaster et al. · American Journal of Hypertension · 1998 · 136 citations · Full text

Hypertension, Lipid Peroxidation, Immunology +20